Inpatient Financial Burden of Atopic Dermatitis in the United States
Research output: Contribution to journal › Journal article › Research › peer-review
Little is known about the inpatient burden of atopic dermatitis (AD). We sought to determine the risk factors and financial burden of hospitalizations for AD in the United States. Data were analyzed from the 2002-2012 National Inpatient Sample, including a 20% representative sample of all hospitalizations in the United States. Hospitalization rates for AD or eczema were highest in the northeast during the winter and south during the summer. Geometric mean cost of care (95% confidence interval) was lower for a primary diagnosis of AD or eczema versus no AD or eczema in adults ($3,502 [$3,360-$3,651] vs. $6,849 [$6,775-$6,925]; P = 0.0004) and children ($2,716 [$2,542-$2,903] vs. $4,488 [$4,302-$4,682]; P = 0.0004). However, the high prevalence of hospitalization resulted in total inpatient costs of $8,288,083 per year for adults and $3,333,868 per year for children. In conclusion, there is a substantial inpatient financial burden of AD in the United States.
|Journal||The Journal of Investigative Dermatology|
|Publication status||Published - 2017|
- Adolescent, Adult, Child, Cost of Illness, Costs and Cost Analysis, Dermatitis, Atopic/economics, Female, Health Care Costs, Hospitalization/economics, Humans, Inpatients, Male, Prevalence, Retrospective Studies, United States/epidemiology, Young Adult